Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05704387

Restrictive- vs Individualized Goal Directed Fluid Therapy in Liver Surgery

Conditions: Surgery-Complications

Sex: All
Ages: 18 Years – 90 Years
Phase: NA
Enrollment: 90
Sponsor: Assistance Publique - Hôpitaux de Paris

Location: France

Summary

"Low central venous pressure (low-CVP) or a restrictive fluid administration strategy is usually used worldwide during major liver resection surgery. Although individualized goal directed fluid therapy (GDFT) has been associated with reduced morbidity and mortality in major abdominal surgery, concerns remain on blood loss when applying GDFT in liver surgery. Indeed, GDFT could lead to a higher CVP with the risk of increased blood loss and reduced quality of the surgical field especially during liver dissection.Since evidence is scarce, this randomized controlled trial investigates the impact of a restrictive vs an individualized GDFT strategy assisted by an assisted fluid management (AFM) system on lactate level, blood loss, and postoperative morbidity including acute kidney injury (AKI) in major liver resections."

Eligibility Criteria

Inclusion Criteria:Adult patientMajor liver surgeryExclusion Criteria:-arrythmia -Linguistic barrier -Pregnant women

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05704387). StuddyBuddy aggregates publicly available trial information.